Sugi Predict

Sugi Predict / Compounds / SCHEMBL3539587

SCHEMBL3539587

SCHEMBL3539587

CN(CCC#N)C1CCN(c2ccc3[nH]c(-c4n[nH]c5cc(F)ccc45)nc3c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 10/20 0.54
▸ FLT1 P17948 10/20 0.54
▸ KDR P35968 2/20 0.54
▸ ABL1 P00519 7/20 0.41
▸ NTRK1 P04629 2/20 0.40
▸ PDPK1 O15530 1/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ CCND3 P30281 1/20 0.38
▸ FLT3 P36888 2/20 0.38
▸ PRKCZ Q05513 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ AURKA O14965 1/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PAK4 O96013 1/20 0.37
▸ LCK P06239 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3536912 0.90 FGFR1 (0.57) FGFR1FLT1KDRABL1NTRK1
SCHEMBL3532399 0.86 FGFR1 (0.62) FGFR1FLT1KDRABL1NTRK1
SCHEMBL13548626 0.85 ABL1 (0.57) FGFR1FLT1KDRABL1PDGFRA
SCHEMBL3538447 0.82 FGFR1 (0.69) FGFR1FLT1KDRABL1NTRK1
SCHEMBL3542465 0.80 FGFR1 (0.45) FGFR1FLT1KDRABL1CDK2
SCHEMBL3540044 0.80 FGFR1 (0.54) FGFR1FLT1KDRABL1NTRK1
SCHEMBL3532401 0.80 FGFR1 (0.73) FGFR1FLT1KDRABL1NTRK1
SCHEMBL3544701 0.78 FGFR1 (0.81) FGFR1FLT1KDRABL1
SCHEMBL5866782 0.78 FGFR1 (0.84) FGFR1FLT1KDRABL1
SCHEMBL3532746 0.77 FGFR1 (0.72) FGFR1FLT1KDRABL1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 — — US disclosed
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 — — US disclosed
US-7642278-B2 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-01-05 — — US disclosed
US-20060079564-A1 Indazole benzimidazole compounds CHIRON CORPORATION 2006-04-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079564-A1 Indazole benzimidazole compounds ABL1, ABL2, ALK FGFR1 886/4885FLT1 2793/4885KDR 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.